Literature DB >> 6516457

Susceptibility of the Lyme disease spirochete to seven antimicrobial agents.

S E Johnson, G C Klein, G P Schmid, J C Feeley.   

Abstract

The antimicrobial susceptibility of five Lyme disease spirochete strains (two human and three tick isolates) was determined. A macrodilution broth technique was used to determine on three separate test occasions the minimal inhibitory concentrations (MICs) of seven antibiotics. The Lyme disease spirochete was most susceptible to erythromycin with a MIC of less than or equal to 0.06 micrograms/ml. The spirochete was also found to be susceptible to minocycline, ampicillin, doxycycline, and tetracycline-HCL with respective mean MICs of less than or equal to 0.13, less than or equal to 0.25, less than or equal to 0.63, and less than or equal to 0.79 micrograms/ml. The spirochete was moderately susceptible to penicillin G with a mean MIC of 0.93 micrograms/ml. All strains were resistant to rifampin at the highest concentration tested (16.0 micrograms/ml).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6516457      PMCID: PMC2590022     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  18 in total

1.  Erythema chronicum migrans Afzelius in Americans.

Authors:  B P FLANAGAN
Journal:  Arch Dermatol       Date:  1962-10

2.  Erythema chronicum migrans with multiple lesions.

Authors:  C E Sonck
Journal:  Acta Derm Venereol       Date:  1965       Impact factor: 4.437

3.  Lyme arthritis appearing outside the United States: a case report from Switzerland.

Authors:  J C Gerster; S Guggi; H Perroud; R Bovet
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-10

4.  Lyme disease-a tick-borne spirochetosis?

Authors:  W Burgdorfer; A G Barbour; S F Hayes; J L Benach; E Grunwaldt; J P Davis
Journal:  Science       Date:  1982-06-18       Impact factor: 47.728

5.  [Lyme arthritis. Inflammatory polyarthritis following migratory annular erythema].

Authors:  G Illouz; J Hewitt
Journal:  Rev Rhum Mal Osteoartic       Date:  1981-12

6.  Lyme arthritis in the Hunter Valley.

Authors:  A Stewart; J Glass; A Patel; G Watt; A Cripps; R Clancy
Journal:  Med J Aust       Date:  1982-02-06       Impact factor: 7.738

7.  Cases of Lyme disease in the United States: locations correlated with distribution of Ixodes dammini.

Authors:  A C Steere; S E Malawista
Journal:  Ann Intern Med       Date:  1979-11       Impact factor: 25.391

8.  Antibiotic therapy in Lyme disease.

Authors:  A C Steere; S E Malawista; J H Newman; P N Spieler; N H Bartenhagen
Journal:  Ann Intern Med       Date:  1980-07       Impact factor: 25.391

9.  [Erythema chronicum migrans with arthritis (author's transl)].

Authors:  R Ackermann; U Runne; W Klenk; C Dienst
Journal:  Dtsch Med Wochenschr       Date:  1980-12-19       Impact factor: 0.628

10.  Susceptibility of Pittsburgh pneumonia agent (Legionella micdadei) and other newly recognized members of the genus Legionella to nineteen antimicrobial agents.

Authors:  A W Pasculle; J N Dowling; R S Weyant; J M Sniffen; L G Cordes; G M Gorman; J C Feeley
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

View more
  28 in total

1.  Comparative in vitro activity of ABT-773, a novel antibacterial ketolide.

Authors:  A M Nilius; M H Bui; L Almer; D Hensey-Rudloff; J Beyer; Z Ma; Y S Or; R K Flamm
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

2.  Elimination of Borrelia burgdorferi and Anaplasma phagocytophilum in rodent reservoirs and Ixodes scapularis ticks using a doxycycline hyclate-laden bait.

Authors:  Marc C Dolan; Terry L Schulze; Robert A Jordan; Gabrielle Dietrich; Christopher J Schulze; Andrias Hojgaard; Amy J Ullmann; Cherilyn Sackal; Nordin S Zeidner; Joseph Piesman
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

3.  Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents.

Authors:  R C Johnson; C B Kodner; P J Jurkovich; J J Collins
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

4.  A multiplex PCR to identify porcine mycoplasmas present in broth cultures.

Authors:  T Stakenborg; J Vicca; P Butaye; H Imberechts; J Peeters; A de Kruif; F Haesebrouck; D Maes
Journal:  Vet Res Commun       Date:  2006-04       Impact factor: 2.459

Review 5.  Antibiotic treatment of animals infected with Borrelia burgdorferi.

Authors:  Gary P Wormser; Ira Schwartz
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

6.  Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis.

Authors:  M Karlsson; S Hammers; I Nilsson-Ehle; A S Malmborg; B Wretlind
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

7.  Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo.

Authors:  J Alder; M Mitten; K Jarvis; P Gupta; J Clement
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

8.  Erythema migrans: three weeks treatment for prevention of late Lyme borreliosis.

Authors:  F Breier; G Kunz; H Klade; G Stanek; E Aberer
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

9.  Ultrastructure of Borrelia burgdorferi after exposure to benzylpenicillin.

Authors:  M Schaller; U Neubert
Journal:  Infection       Date:  1994 Nov-Dec       Impact factor: 3.553

10.  In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents.

Authors:  J M Levin; J A Nelson; J Segreti; B Harrison; C A Benson; F Strle
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.